Technical Analysis for UTRS - Minerva Surgical, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
Parabolic Rise | Strength | 0.00% | |
Upper Bollinger Band Walk | Strength | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Gapped Down | Weakness | 0.00% | |
Calm After Storm | Range Contraction | 2.99% | |
Parabolic Rise | Strength | 2.99% | |
Upper Bollinger Band Walk | Strength | 2.99% | |
Wide Bands | Range Expansion | 2.99% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
Alert | Time |
---|---|
Gapped Down (Full) | 4 days ago |
2x Volume Pace | 4 days ago |
1.5x Volume Pace | 4 days ago |
3x Volume Pace | 4 days ago |
Down 5% | 4 days ago |
Get a Trading Sidekick!
- Earnings date: 03/07/2023
Minerva Surgical, Inc. Description
Minerva Surgical Inc., a commercial-stage medical technology company, focuses on developing, manufacturing, and commercializing minimally invasive solutions to meet the uterine healthcare needs of women. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists across various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
Classification
Sector: Healthcare
Industry: Health Information Services
Keywords: Medicine Medical Technology Ablation Gynaecology Pelvis Invasive Solutions Women's Health Mammal Female Reproductive System
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.04 |
52 Week Low | 0.1499 |
Average Volume | 1,778,558 |
200-Day Moving Average | 1.46 |
50-Day Moving Average | 0.22 |
20-Day Moving Average | 0.26 |
10-Day Moving Average | 0.29 |
Average True Range | 0.08 |
RSI | 64.54 |
ADX | 45.62 |
+DI | 37.54 |
-DI | 12.36 |
Chandelier Exit (Long, 3 ATRs) | 0.41 |
Chandelier Exit (Short, 3 ATRs) | 0.43 |
Upper Bollinger Bands | 0.39 |
Lower Bollinger Band | 0.13 |
Percent B (%b) | 0.93 |
BandWidth | 100.74 |
MACD Line | 0.03 |
MACD Signal Line | 0.02 |
MACD Histogram | 0.0191 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.51 | ||||
Resistance 3 (R3) | 0.51 | 0.46 | 0.49 | ||
Resistance 2 (R2) | 0.46 | 0.42 | 0.46 | 0.48 | |
Resistance 1 (R1) | 0.41 | 0.40 | 0.43 | 0.42 | 0.47 |
Pivot Point | 0.36 | 0.36 | 0.37 | 0.36 | 0.36 |
Support 1 (S1) | 0.32 | 0.33 | 0.34 | 0.32 | 0.27 |
Support 2 (S2) | 0.27 | 0.30 | 0.27 | 0.26 | |
Support 3 (S3) | 0.22 | 0.27 | 0.25 | ||
Support 4 (S4) | 0.23 |